This is a recording from Portland Psychedelic Conference 2018
01:33:19 min
CLEAR ALL
Psychedelic drugs: a dangerous and illegal scourge; a harmless way to “turn on, tune in, drop out” – or a valuable treatment for mental illness? Research is showing that substances like MDMA and magic mushrooms, long banished to society’s fringes, are proving effective in treating...
1
Paul Stamets has been studying psilocybin mushrooms since the mid 1970's. Having written 6 books, including two field guides to psilocybin mushrooms, Paul has named four new psilocybin-active mushroom species.
Ayahuasca’s popularity has exploded in recent years. Once seen as a drug only the most adventurous would seek out and experience, it is now part of the mainstream conversation.
"We met, married and formed a research team about twenty five years ago. This called upon a background of psychedelic drug invention and exploration of the previous twenty years, but it added a new dimension to this area of exploration.
3
Our guest for the first episode of the webinar series will be Mark Haden, Executive Director for MAPS Canada. Mark will be discussing MAPS Canada’s mission, sharing what is currently going on behind the scenes, and also sharing his reflections on the current COVID-19 pandemic.
Mark Haden will explore the history and current research and possible future regulation of psychedelics. He will begin with an overview of indigenous history then explore the history in Canada and why psychedelics were criminalized.
This TEDx talk explores psychedelics in history, the current research and a possible future model of post prohibition regulation based of the model of public health.
Mark Haden is the executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada as well as an adjunct professor at the University of British Columbia School of Public and Population Health.
Bestselling author Tim Ferriss (Tools of Titans, The 4-Hour Workweek, etc.) probes the science, mysteries, and future of psychedelics with Dr. Roland R. Griffiths, a clinical pharmacologist at Johns Hopkins. Dr.